The Effects of a Moderate Weight Loss on Insulin Resistance
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether weight reduction decreases intramyocellular
(IMCL) and hepatic lipid content, and improves insulin sensitivity of muscle and fat tissue
in people who are insulin resistant and have a family history of type 2 diabetes.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Yale University
Collaborators:
Gilead Sciences National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)